资讯
On Monday, the U.S. Food and Drug Administration (FDA) approved Amphastar Pharmaceuticals, Inc.’s (NASDAQ:AMPH) Abbreviated ...
Amphastar Pharmaceuticals (AMPH) upgraded to Buy by Needham after FDA approval for generic iron sucrose injection, marking ...
According to the FDA, Amphastar's iron sucrose injection meets the criteria for bioequivalence and therapeutic equivalence to ...
Generic versions of CSL’s iron replacement therapy Venofer have arrived in the U.S. after a yearslong wait. | Generic ...
2 天
InvestorsHub on MSNAmphastar Shares Rise Following FDA Approval of Generic Iron Sucrose Injection
Amphastar Pharmaceuticals (NASDAQ:AMPH) saw its stock increase by 4% after the company announced that the FDA had approved ...
Viatris (VTRS) stock gains as the FDA OK its generic Iron Sucrose Injection targeting Venofer marketed by Daiichi Sankyo (DSKYF) (DSNKY) and Vifor. Read more here.
2 天
TipRanks on MSNAmphastar announced FDA approval of iron sucrose injection
Pharmaceuticals announced yesterday morning that the Food and Drug Administration approved the company’s abbreviated new drug ...
45 分钟
News-Medical.Net on MSNSurprising sweetness differences in popular U.S. infant formulas
A study on infant formulas reveals significant differences in sweetness, highlighting the impact of ingredients on children's ...
The FSSAI is proposing stricter sugar limits in baby food for children aged 6 to 24 months, amid rising obesity rates. The ...
Venofer was approved in the U.S. in 2000. It was developed by Vifor Pharma, which is now part of CSL Ltd. American Regent, a unit of Daiichi Sankyo, manufactures and sells it in the U.S. under a ...
Learn how and when to feed bees sugar water, the pros and cons of cane vs. beet sugar, GMO myths, feeder types and what ...
Viatris receives US FDA approval for generic iron sucrose injection to treat IDA in chronic kidney disease: Pittsburgh Tuesday, August 12, 2025, 18:00 Hrs [IST] Viatris Inc., a gl ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果